Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
In a separate Phase 2 type-2-diabetes trial, retatrutide lowered HbA1c by up to 2.02 points and cut body weight by about 16.9% at 36 weeks outperforming the GLP-1 agonist dulaglutide[2]
This medical travel support is part of our commitment to making top-tier regenerative care more accessible and convenient
Restricted to laboratory experimentation and cannot be used in clinical or investigational studies, applied in any medical or therapeutic context, or distributed for purposes outside regulated laboratory research
Zepbound Weight Loss Results at 72 Weeks by Dose Mounjaro HbA1c Results for Type 2 Diabetes In the Mounjaro prescribing information, SURPASS-1 (NCT03954834) was a 40-week trial in adults with type 2 diabetes whose blood sugar was not adequately controlled with diet and exercise alone
This gives the tissue time to accommodate the fluid without excessive pressure buildup
These products, particularly when they are injected, can carry significant health risks, including contamination, infection, local tissue damage or potentially life-threatening reactions
